Atenolol

阿替洛尔

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAtenolol
Drug Alias Name氨酰心胺Atenololum苯氧胺atenolol阿坦乐尔 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonistsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelAdrenergic receptorsBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertensionMyocardial InfarctionAngina Pectoris +[4] 
Global Approved IndicationsHypertensionMyocardial InfarctionAngina Pectoris
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1981/08/19
Country/TerritoryUnited StatesIndiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlvogen
China Registration ClassN/A

Develop Information

Active CompaniesAtnahs Pharma Uk LtdTwi PharmaThe Central Pharmaceutical Co Ltd
Inactive CompaniesSandozPostgraduate Institute Of Medical Education And Research
Active IndicationsHypertensionMyocardial InfarctionAngina Pectoris
Inactive IndicationsHemangioma

Other Information

ATC CodeC07AB03
Related LinksWikipediaDrugBankKEGG